Data as of Jan 30
| -0.42 / -0.37%|
Zimmer Holdings, Inc. designs, develops, manufactures, and markets orthopedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products. The company also provides other healthcare related services. The Orthopedic reconstructive devices restore function lost due to disease or trauma in joints, such as knees, hips, shoulders and elbows. The Dental reconstructive implants restore function and aesthetics in patients who have lost teeth due to trauma or disease. The Spinal devices are utilized by orthopedic surgeons and neurosurgeons in the treatment of degenerative diseases, deformities and trauma in all regions of the spine. The Trauma products are devices used primarily to reattach or stabilize damaged bone and tissue to support the body's natural healing process. Its related surgical products include surgical supplies and instruments designed to aid in orthopedic surgical procedures and post-operation rehabilitation. The company operates through three geographic segments: Americas, Europe and Asia Pacific. The Americas segment is comprised principally of the U.S. and includes other North, Central and South American markets. The Europe segment is comprised principally of Europe and includes the Middle East and African markets. The Asia Pacific segment is comprised primarily of Japan and includes other Asian and Pacific markets. Zimmer Holdings was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
|David C. Dvorak||President, Chief Executive Officer & Director|
|Richard C. Stair||Senior VP-Global Operations & Logistics|
|James T. Crines||CFO, Executive VP & Head-Investor Relations|
|Emmanuel Nyakako||SVP-Global Quality, Regulatory & Clinical Affairs|
|Chad F. Phipps||Secretary, Senior Vice President & General Counsel|